uric acid has been researched along with Injuries, Spinal Cord in 13 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Survey of the serum lipoprotein profile, uric acid levels and body weight in Chinese patients with spinal cord injury (SCI) one year after injury, and to report the data of patients with SCI at different levels." | 7.71 | Body weight, serum uric acid and lipid profile one year after spinal cord injury. ( Chu, NK; Tang, FT; Wang, YC; Wong, MK; Wong, PY, 2001) |
| "Survey of the serum lipoprotein profile, uric acid levels and body weight in Chinese patients with spinal cord injury (SCI) one year after injury, and to report the data of patients with SCI at different levels." | 3.71 | Body weight, serum uric acid and lipid profile one year after spinal cord injury. ( Chu, NK; Tang, FT; Wang, YC; Wong, MK; Wong, PY, 2001) |
| "Uric acid (UA) acts as an antioxidant and scavenges free radicals, upregulates glutamate transporters on astrocytes, and preserves neuronal viability in in vitro and in vivo SCI models, making it a promising therapeutic candidate." | 1.62 | Uric acid released from poly(ε-caprolactone) fibers as a treatment platform for spinal cord injury. ( Firestein, BL; Freeman, JW; Khaliq, S; Patel, M; Singh, NK; Vedula, S; Wheeler, N, 2021) |
| "Bladder calculi are a common problem in those with spinal cord injury (SCI)." | 1.32 | Accuracy of bladder stone detection using abdominal x-ray after spinal cord injury. ( Linsenmeyer, MA; Linsenmeyer, TA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (30.77) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, NK | 1 |
| Khaliq, S | 1 |
| Patel, M | 1 |
| Wheeler, N | 1 |
| Vedula, S | 1 |
| Freeman, JW | 1 |
| Firestein, BL | 1 |
| Vidal, J | 1 |
| Javierre, C | 1 |
| Segura, R | 1 |
| Lizarraga, A | 1 |
| Barbany, JR | 1 |
| Pérez, A | 1 |
| Oner-Iyidoğan, Y | 1 |
| Koçak, H | 1 |
| Gürdöl, F | 1 |
| Koçak, T | 1 |
| Erol, B | 1 |
| Linsenmeyer, MA | 1 |
| Linsenmeyer, TA | 1 |
| Scott, GS | 1 |
| Cuzzocrea, S | 1 |
| Genovese, T | 1 |
| Koprowski, H | 1 |
| Hooper, DC | 1 |
| Rodriguez, GP | 1 |
| Claus-Walker, J | 2 |
| Zhong, YG | 1 |
| Levy, E | 1 |
| Bauman, WA | 2 |
| Adkins, RH | 1 |
| Spungen, AM | 1 |
| Kemp, BJ | 1 |
| Waters, RL | 1 |
| Wong, PY | 1 |
| Wang, YC | 1 |
| Chu, NK | 1 |
| Tang, FT | 1 |
| Wong, MK | 1 |
| Rodriguez, G | 1 |
| Burr, RG | 1 |
| Sharma, S | 1 |
| Vaidyanathan, S | 1 |
| Thind, SK | 1 |
| Nath, R | 1 |
| Sankaranarayanan, A | 1 |
| Roussan, MS | 1 |
| Gordon, S | 1 |
2 trials available for uric acid and Injuries, Spinal Cord
| Article | Year |
|---|---|
The relationships among serum uric acid, plasma insulin, and serum lipoprotein levels in subjects with spinal cord injury.
Topics: Adult; Aged; Carbohydrates; Cholesterol; Glucose Tolerance Test; Humans; Insulin; Lipoproteins; Male | 1995 |
The effect of residual neurological deficit on serum lipoproteins in individuals with chronic spinal cord injury.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Female; Humans; Lipids; Lipoproteins; Ma | 1998 |
11 other studies available for uric acid and Injuries, Spinal Cord
| Article | Year |
|---|---|
Uric acid released from poly(ε-caprolactone) fibers as a treatment platform for spinal cord injury.
Topics: Animals; Antioxidants; Delayed-Action Preparations; Polyesters; Rats; Rats, Sprague-Dawley; Reactive | 2021 |
Physiological adaptations to exercise in people with spinal cord injury.
Topics: Adaptation, Physiological; Blood Glucose; Blood Pressure; Body Temperature; Cardiovascular Physiolog | 2003 |
Urine 8-isoprostane F2alpha concentrations in patients with neurogenic bladder due to spinal cord injury.
Topics: Adult; Antioxidants; Dinoprost; F2-Isoprostanes; Female; Humans; Male; Malondialdehyde; Middle Aged; | 2004 |
Accuracy of bladder stone detection using abdominal x-ray after spinal cord injury.
Topics: Adult; Calcium Oxalate; Calcium Phosphates; Cystoscopy; Female; Humans; Magnesium Compounds; Male; P | 2004 |
Uric acid protects against secondary damage after spinal cord injury.
Topics: Animals; Cells, Cultured; Immunohistochemistry; Lipid Peroxidation; Male; Mice; Neurons; Neutrophils | 2005 |
Urinary in vitro sedimentation: effects of nondialyzable components and heparin.
Topics: Calcium; Crystallization; Dialysis; Heparin; Humans; Hydrogen-Ion Concentration; Hydroxyproline; Mac | 1981 |
Body weight, serum uric acid and lipid profile one year after spinal cord injury.
Topics: Adult; Aged; Body Weight; Cholesterol, HDL; Female; Humans; Lipids; Male; Middle Aged; Spinal Cord I | 2001 |
In vitro aggregations in solutions simulating urine.
Topics: Calcium; Hydrogen-Ion Concentration; Nitrogen; Proteus; Spinal Cord Injuries; Uric Acid; Urinary Cal | 1979 |
Urinary calculi composition in patients with spinal cord lesions.
Topics: Calcium; Calcium Phosphates; Carbonates; Female; Humans; Magnesium; Male; Phosphates; Quaternary Amm | 1978 |
The effect of diclofenac sodium on urinary concentration of calcium, uric acid and glycosaminoglycans in traumatic paraplegics.
Topics: Adult; Calcium; Depression, Chemical; Diclofenac; Female; Glycosaminoglycans; Humans; Male; Middle A | 1991 |
Effect of a new antispasticity drug on neurogenic bladder function: preliminary report.
Topics: Adult; Aminobutyrates; Benzene Derivatives; Female; Humans; Male; Middle Aged; Multiple Sclerosis; M | 1973 |